Prostate Cancer

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose-rate brachytherapy boost (LDR-PB) achieves better rates of biochemically disease-free outcomes in prostate cancer.

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

Adding short-term androgen deprivation therapy to radiotherapy does not improve overall survival in intermediate-risk prostate cancer.

Early Bicalutamide Aids Survival in Nonmetastatic Prostate Cancer

Early Bicalutamide Aids Survival in Nonmetastatic Prostate Cancer

Adding bicalutamide improves overall survival among patients with advanced nonmetastatic hormone-naïve prostate cancer.

Prostate Cancer Active Surveillance Outcomes Vary by Disease Risk

Prostate Cancer Active Surveillance Outcomes Vary by Disease Risk

By

Cancer-specific and overall survival is decreased in men with intermediate-risk versus low-risk tumors.

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

By

Researchers observed a significant 36% decreased overall and prostate cancer-specific mortality.

New Tool Could Spare Men Unnecessary Prostate Biopsies

New Tool Could Spare Men Unnecessary Prostate Biopsies

By

The 4Kscore enables better identification of men who harbor high-grade prostate cancer.

Radiation Plus ADT Beneficial in Node-Positive Prostate Cancer

Radiation Plus ADT Beneficial in Node-Positive Prostate Cancer

By

The 5-year risk of overall mortality is decreased by 50% compared with androgen deprivation therapy alone.

Better mCRPC Survival with Docetaxel Followed by Abiraterone

Better mCRPC Survival with Docetaxel Followed by Abiraterone

By

This medication sequence was associated with longer progression-free and overall survival compared with the reverse.

Genitourinary Cancer in Siblings Raises Personal Risk

Genitourinary Cancer in Siblings Raises Personal Risk

By

Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.

Adding Statins to ADT May Delay PCa Progression

Adding Statins to ADT May Delay PCa Progression

By

Prostate cancer progression was delayed by a median 10 months in statin users.

Testicular Cancer May Raise Risk of Prostate Tumors

Testicular Cancer May Raise Risk of Prostate Tumors

By

A history of testicular cancer was associated with a greater likelihood of prostate cancer overall and intermediate- or high-risk disease.

Delaying Prostatectomy Appears Safe for AS Patients

Delaying Prostatectomy Appears Safe for AS Patients

By

No higher risk of adverse pathology among men on active surveillance who delayed surgery until signs of disease progression.

Higher-Risk Prostate Cancer On the Rise

Higher-Risk Prostate Cancer On the Rise

By

The proportion of men diagnosed with intermediate- or high-risk disease rose 6% from 2011 to 2013, study finds.

Suicide Among Genitourinary Cancer Patients

Suicide Among Genitourinary Cancer Patients

Risk factors include male gender, distant disease, increasing age, race/ethnicity

Radiotherapy Common for Prostate Cancer

Radiotherapy Common for Prostate Cancer

Research raises concerns about possible overuse of radiation therapy

Prostatectomy May Impair Sex for Women, Too

Prostatectomy May Impair Sex for Women, Too

Sexual function declines for both men and women following radical prostatectomy, but some aspects of care may help couples.

Increasing Observation of Younger Men with PCa

Increasing Observation of Younger Men with PCa

From 2004 to 2009, there was a marked increase in observation (watchful waiting and active surveillance) among men with low-risk prostate cancer.

Prostatectomy for Low Risk PCa Varied by Surgeon

Prostatectomy for Low Risk PCa Varied by Surgeon

Variation exists at a high-volume center when selecting patients with low-risk prostate cancer for prostatectomy.

New Guideline for PCa Survivor Care Endorsed by ASCO

New Guideline for PCa Survivor Care Endorsed by ASCO

Guideline outlines recommended follow-up care for prostate cancer survivors

Underdiagnosis Common Among PCa Active Surveillance Candidates

Underdiagnosis Common Among PCa Active Surveillance Candidates

By

Just over 41% of patients eligible for active surveillance by European standards were found to have undergraded prostate cancer.

Salvage Prostate Cryoablation Promising

Salvage Prostate Cryoablation Promising

Focal and whole-gland approaches may provide alternatives for recurrent PCa after radiotherapy

Abiraterone Improves Castration-Resistant PCa Survival

Abiraterone Improves Castration-Resistant PCa Survival

By

Patients who received the drug as part of their treatment survived longer than those on placebo by a median 4.4 months.

Delaying Prostate Cancer Surgery Safe in Low-Risk Patients

Delaying Prostate Cancer Surgery Safe in Low-Risk Patients

By

Researchers find no increased risk of adverse pathologic outcomes among men who put off radical prostatectomy for up to 12 months.

Prostate Cancer Not More Common in Hemophiliacs

Prostate Cancer Not More Common in Hemophiliacs

By

Patients with hemophilia, however, do have a higher incidence of cancers overall.

Erectile Dysfunction Drugs May Worsen Prostate Cancer Surgery Outcomes

Erectile Dysfunction Drugs May Worsen Prostate Cancer Surgery Outcomes

By

Men who take phosphodiesterase type 5 inhibitors after radical prostatectomy are more likely to experience biochemical recurrence of disease.

Smoking History Important for Prostate Cancer Survival

Smoking History Important for Prostate Cancer Survival

Former, as well as current, smokers saw higher risk for radiation treatment-related urinary side effects.

MRI-Guided Prostate Biopsy Spots More Aggressive Tumors

MRI-Guided Prostate Biopsy Spots More Aggressive Tumors

Magnetic resonance imaging technology with ultrasound found 30% more high-risk prostate cancers and 17% fewer low-risk cancers.

Sign Up for Free e-newsletters